How to Know If Your Antidepressant Is Working When Your Mood Still Feels Off

You have been taking the medication for three weeks. Your mood is still dark. You still feel heavy and disconnected. You are starting to think it is not working.

It might not be working. But it is also possible that it is working, and you cannot tell yet, because depression itself impairs the ability to accurately assess your own mental state, and because mood is not the first thing to improve on an antidepressant. Not by a long way.

Understanding what early antidepressant response actually looks like, and what to track when you are not sure if anything is changing, is one of the most practically useful things a prescriber can give a patient at the start of treatment. Most patients do not receive it.

Why Mood Is the Last Thing to Improve

Antidepressants change brain chemistry relatively quickly: synaptic serotonin increases within hours of the first dose. But the clinical benefits require a different process: gradual downregulation of serotonin receptors, normalization of stress hormone systems, and neuroplastic changes in circuits that regulate emotional experience. These changes take weeks to accumulate.

The order in which they accumulate is not random. Physical symptoms of depression, including disrupted sleep, appetite loss, fatigue, and reduced energy, tend to respond earlier than the core mood symptoms of sadness, hopelessness, and loss of interest. Cognitive symptoms, including concentration difficulty and slowed thinking, often improve in the intermediate phase. Mood itself, the subjective experience of feeling better, typically appears last.

This means a patient at week 3 who is sleeping somewhat better and finding it easier to concentrate may actually be responding well to the medication, even though they still feel depressed in the deeper sense. Stopping at this point discards a medication that was beginning to work.

The Three-Part Structure of Antidepressant Response

Depression has three broad symptom domains, and antidepressants tend to address them in sequence:

Physical / Somatic Domain (Often First)

• Sleep quality: falling asleep more easily, staying asleep, waking feeling more rested

• Energy: less persistent fatigue, increased capacity for basic daily activities

• Appetite: noticing hunger cues again, eating more regularly

• Physical heaviness: the literal sense of your body being difficult to move beginning to lift

Cognitive Domain (Often Intermediate)

• Concentration: ability to focus on tasks, follow conversations, read for longer periods

• Decision-making: less paralysis, more ability to take small actions

• Negative thought volume: rumination and self-critical thinking beginning to reduce

• Cognitive engagement: starting to reengage with things previously abandoned

Mood and Affect Domain (Often Last)

• Sadness: the baseline heaviness of feeling beginning to lift

• Anhedonia: reconnecting with interest in activities and relationships

• Hopelessness: beginning to feel that the future is possible

• Emotional range: experiencing a wider range of emotions, not just the flat weight of depression

When patients ask “is my antidepressant working,” they are usually asking about the third domain. The answer may be “not yet” while the first two domains are already showing meaningful improvement.

What Early Response Actually Looks Like

Early response is a clinically significant signal. APA practice guidelines recommend assessing clinical response within the first 2 to 4 weeks of a new antidepressant trial specifically because early symptom movement informs treatment planning and the calibration of patient expectations. A prescriber who sees a modest but measurable improvement at week 2 has different information than one who sees no movement at all.

What early response looks like in practice:

• Sleeping through more nights than not, where before you were waking frequently or lying awake

• Completing tasks that previously felt impossible, without the same degree of effort

• Noticing small moments of engagement or interest, even brief ones, in things you had stopped caring about

• Finding that you have more good hours within a day, even if the day overall still feels heavy

• Feeling less completely preoccupied by negative thoughts, even if they are still present

None of these are dramatic. That is the point. Early response is incremental. It accumulates across weeks. The question to ask yourself is not “am I better?” but “is anything different today than it was two weeks ago, in any of these specific areas?”

Why People Around You Notice Before You Do

Depression impairs self-assessment in a specific and consistent way: patients on effective treatment systematically underestimate their own improvement. The cognitive distortions that are part of the illness, particularly the tendency to discount positive information and weight negative information more heavily, continue to operate even as objective functioning improves.

This is why people close to you often notice behavioral changes before you experience them as feeling better. Your sleep improved, so you are less visibly exhausted. You are engaging more in conversations. You completed a project. These behavioral signals are visible to others before they register as feeling meaningfully better to you.

This is not a minor clinical detail. It is a practical reason to track specific, observable behaviors rather than relying entirely on the question “do I feel better,” which depression itself may consistently answer as “no” even when meaningful improvement is occurring.

How to Track Your Response Without Relying on Memory

The most reliable way to assess antidepressant response is with a validated instrument administered consistently over time. The PHQ-9 is a 9-item self-report instrument validated for measuring depression severity and tracking treatment response. Its sensitivity to change over time is one of its primary clinical applications, and using it at regular intervals produces the trajectory data that makes treatment-response assessment evidence-based.

Without a validated instrument, tracking can still be meaningful if it is specific and consistent. Useful things to track daily or weekly:

• Sleep quality: number of hours, number of wakings, how you feel on waking

• Energy level: rated on a simple scale, at a consistent time of day

• Number of tasks completed that previously felt impossible

• Brief notes on mood, appetite, or social engagement

The goal is a record you can compare week to week, not a day-to-day judgment about whether you feel better. Depression creates day-to-day variation. The trend over two to four weeks is what matters clinically.

Signs the Medication May Not Be Working

Distinguishing normal slow response from genuine non-response requires honesty about what is changing. Signs that warrant a prescriber conversation:

• No change in any of the three symptom domains at 6 to 8 weeks at a therapeutic dose

• Symptoms actively worsening rather than staying flat

• New or worsening thoughts of self-harm or suicide: contact your prescriber immediately or call 988

• Side effects that are impairing your quality of life to a degree that outweighs any benefit

• Emotional blunting so complete that you feel neither better nor anything else

Research on antidepressant adherence consistently finds that approximately 60% of patients stop within three months, most during the peak side effect window before therapeutic benefit is established. The most common reason is not that the medication was not working. It is that the patient did not have the information or support to get through the early weeks.

How SiggyMD Tracks Early Response

SiggyMD’s daily check-ins track the specific indicators that signal early antidepressant response: sleep quality, energy, appetite, concentration, and mood, using structured daily prompts rather than asking the patient to reconstruct their experience at a quarterly appointment. The resulting data is not a daily mood score. It is a trajectory: a week-by-week record that shows whether the medication is having measurable effects in the physical and cognitive domains before mood changes become obvious.

“Most patients who are actually responding don’t feel like they’re responding in the first few weeks,” says Daniel Montville, MD, Psychiatrist at SiggyMD. “The sleep data usually tells me first. Then energy. Mood comes later. When I can show a patient that their sleep improved measurably over the last 10 days, even though they don’t feel meaningfully better yet, that is often the information that convinces them to stay on the medication long enough to get to the actual benefit. Without that data, I’m asking them to trust a feeling that depression is actively distorting.”

What Members Are Saying

NF

N.F., 35

Major Depressive Disorder

“At week 3 I was convinced nothing was happening. My prescriber pulled up my check-in data and showed me that my sleep scores had been improving consistently for two weeks. I hadn’t noticed because I was still focused on my mood. She said that was the medication working in the early phase. She was right. By week 6 I was genuinely better.”

SW

S.W., 27

Persistent Depressive Disorder

“I had been on this medication for four weeks and was about to ask to switch. My prescriber showed me that my concentration scores had improved, I was eating more regularly, and I had logged three days in a row with higher energy. I was not aware of any of this until I saw it laid out across a month. My mood was still low but things were moving.”

Member stories reflect real experiences. Names and identifying details have been changed to protect privacy. Results vary. SiggyMD is currently invite-only.

Bottom Line

When your mood still feels off at week 3 or 4, that does not necessarily mean your antidepressant is not working. Mood is typically the last symptom domain to improve. Sleep, energy, concentration, and appetite often respond first.

Tracking these specific indicators, rather than relying on the global question of whether you feel better, is the most useful thing you can do in the early weeks of antidepressant treatment. Depression distorts self-assessment. Data does not. A prescriber who can see your sleep trajectory, your energy scores, and your adherence patterns has a fundamentally better picture of whether the medication is beginning to work than one relying on a single appointment conversation at week 8.

Sources

• American Psychiatric Association. Practice Guideline for the Treatment of Patients with Major Depressive Disorder. APA. Accessed June 2026.

• Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: Validity of a Brief Depression Severity Measure. Journal of General Internal Medicine. 2001;16(9):606-613.

• Rossom RC, et al. Antidepressant Adherence Across Diverse Populations and Healthcare Settings. Depression and Anxiety. 2016;33(8):765-774.

• NIHR Evidence. A fifth of people who have no improvement on antidepressants at four weeks respond if given more time. NIHR Evidence. Accessed June 2026.

• Jha MK, Trivedi MH. Mechanisms of treatment-resistant depression: a complex interplay of neurobiological, clinical, and environmental factors. Frontiers in Psychiatry. 2023;13:1095977.

• National Institute of Mental Health. Depression: Overview. NIMH. Accessed June 2026.